Opdivo gets the subQ (under the skin) approval from FDA Keytruda subQ is next on deck Bristol Myers Squibb exec told @endpts.com they expect ~30-40% of eligible patients will switch from IV version of the blockbuster cancer immunotherapy - ThreadSky

kylelahucik.bsky.social • 62 days ago

Opdivo gets the subQ (under the skin) approval from FDA

Keytruda subQ is next on deck

Bristol Myers Squibb exec told @endpts.com they expect ~30-40% of eligible patients will switch from IV version of the blockbuster cancer immunotherapy

Comments

Posting Rules

Comments

Posting Rules

Reply